Organon
E554058
Organon is a global pharmaceutical company specializing in women's health, biosimilars, and established medicines, formed as a spin-off from Merck & Co.
Statements (38)
| Predicate | Object |
|---|---|
| instanceOf |
pharmaceutical company
ⓘ
public company ⓘ |
| alsoKnownAs | Organon & Co. NERFINISHED ⓘ |
| coreTherapeuticArea |
biosimilars
ⓘ
established brands ⓘ women's health ⓘ |
| corporateForm | publicly traded corporation ⓘ |
| countryOfHeadquarters |
United States of America
ⓘ
surface form:
United States
|
| focusesOn |
access to medicines for women
ⓘ
expanding global reach of established brands ⓘ |
| formedBy | corporate spin-off ⓘ |
| hasBusinessFocus |
biosimilar immunology products
ⓘ
biosimilar oncology products ⓘ cardiovascular medicines ⓘ contraception ⓘ fertility treatments ⓘ pain management medicines ⓘ reproductive health ⓘ respiratory medicines ⓘ |
| hasGlobalPresence | yes ⓘ |
| hasOrigin | reorganization of Merck & Co. business units ⓘ |
| hasStrategicPriority |
growth in biosimilars market
ⓘ
maximizing value of established medicines portfolio ⓘ women-centered healthcare solutions ⓘ |
| industry | pharmaceuticals ⓘ |
| operatesInSector | healthcare ⓘ |
| operatesInSubsector | pharmaceutical manufacturing ⓘ |
| parentCompanySpinOffFrom | Merck & Co. NERFINISHED ⓘ |
| productPortfolioIncludes |
biosimilar medicines
ⓘ
branded pharmaceuticals ⓘ legacy medicines ⓘ |
| servesMarket | global ⓘ |
| specializesIn |
biosimilars
ⓘ
established medicines ⓘ women's health ⓘ |
| spinOffFrom | Merck & Co. NERFINISHED ⓘ |
| stockExchangeListing | New York Stock Exchange ⓘ |
| tickerSymbol | OGN NERFINISHED ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.